EZH2 and non-small cell lung carcinoma: To the best of our knowledge, our results suggested that the miR‐30b‐5p shuttled by BMSC‐derived exosomes could inhibit the progression of NSCLC by targeting EZH2 via suppression of PI3K/AKT signalling pathway.